CD79B and diffuse large B-cell lymphoma: Inclusion of this extranodal branch of DLBCL in future classification systems may be warranted because these malignancies tend to share similar genetic alterations, such as a high prevalence of MYD88L265P and CD79B mutations, which are also defining characteristics of MCD/C5 genetic subgroups, which are to be expanded upon further in this review.